相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial
Chiun Hsu et al.
LUNG CANCER (2008)
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
Kyung-Hun Lee et al.
LUNG CANCER (2008)
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer
Richard Booton et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy
Koichi Azuma et al.
CANCER SCIENCE (2007)
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer
George Simon et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression:: A phase III trial in non-small-cell lung cancer
Manuel Cobo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Concomitant chemoradiation versus radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: Final result of a phase III trial
A. Sharma et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer
Zhong Zheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular mechanisms of resistance and toxicity associated with platinating agents
Cara A. Rabik et al.
CANCER TREATMENT REVIEWS (2007)
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
P. Ceppi et al.
ANNALS OF ONCOLOGY (2006)
Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men
Robert James Cerfolio et al.
CHEST (2006)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors
A Italiano et al.
ANNALS OF ONCOLOGY (2006)
ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer
GR Simon et al.
CHEST (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Lung cancer in women - Analysis of the national surveillance, epidemiology, and end results database
JB Fu et al.
CHEST (2005)
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group
F Fossella et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases
E Radzikowska et al.
ANNALS OF ONCOLOGY (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
